相关实验视频

Updated: Jul 2, 2025

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

在阿片类药物使用障碍和相关行为中肠道微生物组的影响

Bridget Herlihy^1,2, Sabita Roy¹

¹Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, United States.

Advances in drug and alcohol research

|February 23, 2024

概括

在阿片类药物使用期间肠道微生物组的变化会影响成行为. 防止这些微生物转移可能为物质使用障碍 (SUD) 提供新的治疗策略.

科学领域:

神经科学是一个神经科学.
微生物学微生物学
药理学药理学是指药理学的学科.

背景情况:

药物使用障碍 (SUD) 是一种慢性,复发性脑疾病,具有重大的全球健康后果.
目前对SUD的治疗方法往往无法解决潜在的行为和心理症状,导致复发率高.
特别是阿片类药物成,其特点是与药物使用和戒断相关的复杂行为变化.

研究的目的:

审查当前对肠道微生物组与阿片类药物使用障碍 (OUD) 的行为变化之间的关系的理解.
探索将微生物组作为OUD治疗策略的潜力.
确定需要进一步研究的关键知识差距,以阐明成中的微生物组行为机制.

主要方法:

对调查SUD患者,特别是OUD患者肠道微生物组合的研究进行文献综述.
对探索阿片类药物暴露对微生物群落影响的研究进行分析.
综合关于微生物代谢物或变化如何影响神经生物学和行为的发现.

主要成果:

阿片类药物使用与肠道微生物群多样性和组成的显著改变有关.
有证据表明,这些微生物组变化可以调节与药物相关的行为,包括戒断症状和寻找药物.
特定的微生物物种或其代谢副产品可能在阿片类药物影响的神经生物学途径中发挥作用.

结论:

肠道微生物组代表了一个潜在的,但尚未被充分探索的治疗点,用于管理OUD.
进一步的研究对于充分理解将微生物组与成相关行为联系起来的因果机制至关重要.
开发针对微生物组的干预措施可以提供新的方法来预防复发并改善SUD的治疗结果.

关键词:

行为行为行为行为.肠道-大脑肠道-大脑微生物组是一个微生物组."阿片类药物使用障碍"药物使用障碍物使用障碍物.撤回撤回撤回撤回

更多相关视频

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

相关概念视频

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...

Drug Abuse and Addiction: Pharmacological Phenomena

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...

Opioid Receptors: Overview

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...